Clinical Trial Update: Pazopanib for Metastatic Alveolar Soft Part Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial of Pazopanib for metastatic alveolar soft-part sarcoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Soft Part Sarcoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Metastatic Alveolar Soft Part Sarcoma | Phase 2 | Status: TERMINATED